Concord Medical Services Holdings Limited
Concord Medical Services Holdings Limited (CCM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ccm · stock forecast · 2 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $4.78
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $4.66 | ↓ 2.45% |
1-day model range: $4.61–$4.72. Peak: $4.72 (-2.45%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | -46.0% |
| 2028 | $2 | -58.4% |
| 2029 | $2 | -63.2% |
| 2030 | $2 | -65.3% |
| 2031 | — | -66.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CCM · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2012-11-23 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2012-07-06 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2012-03-22 | JP Morgan | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Concord Medical Services Holdings Limited (CCM) stock. Of the recent 3 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover CCM.
Analyst Recommendation Trends
CCM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$245M
↑ 1.2% YoY
Revenue Next Year
$184M
↓ 24.8% YoY
EPS This Year
$4.18
EPS Next Year
$-7.03
↓ 268.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast CCM EPS of $4.18 for the current fiscal year, based on estimates from 1 analysts. The CCM revenue forecast is $245M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CCM stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CCM price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The CCM short-term stock prediction for tomorrow is $4.66 (-2.45%). The CCM stock price prediction for 2027 estimates an average of $3. The CCM stock prediction for 2030 projects a range of $1–$2.
Concord Medical Services Holdings Limited trades on NYSE under the ticker CCM. The CCM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CCM forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month CCM price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $4.78.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.